Le Lézard
Classified in: Health
Subject: AVO

Founder of the Free From Fibroids Foundation Asks Important Question: Is Hysterectomy Obsolete For Uterine Fibroids?


WASHINGTON, Sept. 21, 2021 /PRNewswire-PRWeb/ -- The founder of the Free From Fibroids Foundation, Dr. John Lipman shares his thoughts on why Congress must pass the bipartisan Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2021 (S. 2444/H.R. 2007) and why it's critical to empower women with information about all of their treatment options as they battle uterine fibroids.

Dr. Lipman's thoughts are below:

Sixty years ago, the civil rights icon Fannie Lou Hamer, who made famous the phrase "I'm sick and tired of being sick and tired," had a hysterectomy without her consent for the treatment of uterine fibroids. Mrs. Hamer shared her experience and coined the phrase "Mississippi Appendectomy," the forced sterilization of poor Black women under the pretext of treating other gynecological health issues.

A systemic failing in our healthcare system is causing women, mostly Black and women of color, to unnecessarily have their uterus removed through hysterectomy for the treatment of fibroids. The majority of these hysterectomies are not occurring because the women want to lose their uterus, it is because they are told by their physician that hysterectomy is their only option to end the suffering they have been dealing with for so many years.

Annually nearly 600,000 hysterectomies are performed, making it the second most common surgery performed in the United States, and fibroids are the number one reason for hysterectomy.

Hysterectomy should be an option of last resort for women suffering from fibroids.

Uterine fibroids are the most common pelvic tumor seen in women. These benign, non-cancerous growths of various sizes are made up of muscle fibers and connective tissue. Nearly two-thirds of women by age 50 are impacted by fibroids and Black women are diagnosed with fibroids nearly three times as frequently as white women.

While fibroids are typically not fatal, they often make women's lives miserable. Symptoms include horribly heavy and lengthy periods, monthly abdominal and pelvic pain, pressure from the enlarged, pregnant-appearing uterus, and increased urinary frequency.

One aggressive driver of the excessive number of unnecessary hysterectomies for uterine fibroids is the significant resources and influence that the pharmaceutical and surgical device manufacturers have on physicians and hospitals to perpetuate this "status quo" of hysterectomy.

I see patients every day who are suffering from fibroids and don't want a hysterectomy. They simply want their life back. Hysterectomies take away a woman's ability to bear children, but also do more to a woman's body after the surgical wounds heal.

It's time to challenge the outdated practice of performing life-changing, unnecessary hysterectomy without first considering much safer, less expensive, and less invasive non-surgical options like Uterine Fibroid Embolization (UFE).

With a 25-year track record of safety and efficacy, UFE is performed by medical specialists known as interventional radiologists, is covered by Medicare, Medicaid, and commercial insurance, and is endorsed by the American College of Obstetricians & Gynecologists.

In marked contrast to hysterectomy, women choosing UFE undergo a brief outpatient procedure and are discharged home the same day with just a Band-Aid. Most importantly, women are able to keep their uterus.

Congress has an opportunity to help in this fight against fibroids and unnecessary hysterectomies and take an important step toward empowering and supporting women by passing the bipartisan Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2021 (S. 2444/H.R. 2007). This overdue legislation will provide research to try to find out where fibroids come from and how to prevent them and best treat them.

                                                                                        ###

About the author:

Dr. John Lipman is a board-certified Interventional Radiologist and renowned authority in the non-surgical treatment of uterine fibroids. He is the founder and chairman of the Free From Fibroids Foundation and the Fibroid Coalition.

Dr. Lipman is the President & CEO of the Atlanta Fibroid Center and is also an Adjunct Clinical Assistant Professor in the Department of Obstetrics & Gynecology at Morehouse School of Medicine. Learn more about Dr. Lipman's work with the Free From Fibroids Foundation at freefromfibroids.org.

Media Contact

Dr. John Lipman, Free From Fibroids Foundation, +1 (202) 552-1708, [email protected]

 

SOURCE Free From Fibroids Foundation


These press releases may also interest you

at 09:01
The German group around EIS/Satisfyer/Triple A has purchased the entire product portfolio, patents, designs and brands as well as the inventory of FUN FACTORY as part of an asset deal effective on October 1st, 2024 and has already placed a reorder of...

at 09:00
Zhao Yan, Chairperson and CEO of Bloomage, attended the 15th Annual Meeting of the New Champions (Summer Davos Forum) organized by the World Economic Forum to offer insights on navigating the current uncertainties in the global economy. This year's...

at 07:32
Duchesnay Pharmaceutical Group (DPG), one of the eight companies across the country chosen to participate in the Government of Canada's Global Hypergrowth Project, is very proud to announce that it has been awarded the Parity Certificationtm by Women...

at 06:30
The global microscopy market is poised for significant growth, expected to reach USD 10.6 billion by 2029 from USD 8.1 billion in 2024, growing at a CAGR of 5.4%. Key drivers include rising cases of chronic diseases necessitating effective...

at 06:25
Genexine (KOSDAQ: 095700), a publicly-listed, clinical-stage Korean biopharmaceutical company committed to the discovery and development of novel biologics for the treatment of serious unmet medical needs, announced a merger with EPD Biotherapeutics...

at 06:03
The IAMStm brand, proudly part of the Mars family of brands, announced today the launch of the IAMStm Puppy Hub and Kitten Hub, two online tools featuring expert knowledge and advice for new and soon-to-be pet parents. Each Hub will bring...



News published on and distributed by: